
Receiving a diagnosis of age-related macular degeneration (AMD) can bring profound emotional challenges, especially as your central vision, independence, and daily routines begin to feel threatened. We deeply understand the fear and uncertainty that accompany progressive vision loss, and we want you to know that compassionate, advanced care is available to support you. Traditional treatments often focus solely on managing symptoms or slowing fluid buildup in wet forms of the disease, leaving many patients searching for ways to actively support their remaining retinal health. This specialized stem cell therapy package at Integra Medical Center in Nuevo Progreso, Mexico, is carefully designed to offer potential retinal support for those navigating this difficult journey, providing access to emerging regenerative cellular therapies in a warm, patient-centered environment.
When you arrive at our dedicated facility, our empathetic medical team will guide you through every step of the process with the utmost care. This package encompasses your complete treatment experience, seamlessly integrating your initial in-depth medical evaluations, the specialized administration of stem cells, and the crucial early stages of aftercare. Regenerative medicine introduces a distinctly different approach, utilizing the unique biological properties of stem cells to potentially provide trophic support and foster a healthier environment for surviving retinal cells. Whether you are dealing with dry AMD or stable wet macular degeneration, this protocol focuses on cellular nourishment, tissue preservation, and overall ocular stabilization.
While preliminary estimates indicate that package costs start around $5,500 to $7,500 USD, please understand that your exact pricing and medical eligibility must be determined through a personalized, thorough evaluation by our treating physicians. You can expect an initial stay of about three to four days in Nuevo Progreso to ensure a safe, unhurried treatment experience and immediate post-procedure observation. Your safety, comfort, and ongoing ocular health remain our absolute highest priorities as we explore the possibilities of regenerative medicine together to help protect your daily quality of life.
Estimated Package Price and Cost Breakdown
Understanding the financial commitment involved in international regenerative medicine is an essential part of your decision-making process. We believe in complete transparency, which is why we want to provide you with a clear baseline of what to expect. Because every patient's cellular requirements and ocular health conditions are deeply personal and unique, a one-size-fits-all price is impossible to guarantee without direct diagnostic review.
Important Note: The figures below represent estimated starting costs for our baseline protocols. The final package price will depend heavily on the source of the stem cells, the required dosage or cell count, and the specific administration methods prescribed by the attending physician.
| Service Category | Estimated Cost / Details |
|---|---|
| Stem Cell Therapy Package (Base) | $5,500 - $7,500 USD (Starting Estimate) |
| Initial Specialist Medical Consultation | Included in Base Package |
| Stem Cell Processing and Laboratory Preparation | Included in Base Package |
| Clinical Administration (Intravenous/Localized) | Included in Base Package |
| Post-Procedure Nursing & Observation | Included in Base Package |
| International Travel & Accommodation | Not Included (Patient Responsibility) |
Standard Package Inclusions
To ensure transparency, here are the core clinical services generally included in the estimated package cost to facilitate a safe and comfortable treatment experience:
- ✓ Initial Medical Consultation: Face-to-face evaluation with our regenerative medicine specialist to map out your treatment plan.
- ✓ Pre-Procedure Clearance: Thorough physical evaluation and review of vital signs upon arrival at the center.
- ✓ Cellular Processing: Complete laboratory handling, biological processing, purification, and quality control of the administered stem cell product.
- ✓ Procedure Administration: The clinical application of stem cells performed by qualified medical professionals using standard sterile protocols.
- ✓ Facility and Nursing Fees: All clinical room charges, disposable medical supplies, local anesthetics (if required), and nursing support throughout your stay.
- ✓ Bilingual Patient Coordination: Dedicated assistance from English-speaking team members to help with translation and clinic logistics.
Package Exclusions
To prevent unexpected out-of-pocket expenses, families should plan for the following items which are not covered in the medical package price:
- ✗ Travel and Logistics: Airfare, gasoline, tolls, and transportation to the Texas/Mexico border region.
- ✗ Accommodation: Hotel stays or lodging in Nuevo Progreso or neighboring border towns.
- ✗ Daily Personal Expenses: Meals, shopping, and leisure activities during your stay.
- ✗ Pre-Travel Diagnostic Imaging: Initial OCT scans, fluorescein angiograms, or eye exam reports conducted by your home eye specialists prior to traveling.
- ✗ Unrelated Medical Care: Interventions for pre-existing conditions unrelated to your macular degeneration therapy.
- ✗ Long-Term Daily Medications: Prescription eye drops, dietary supplements, or general maintenance drugs purchased for long-term home use.
Who is a Candidate for This Treatment?
Stem cell therapy is not a universal remedy and requires careful patient selection. Potential candidates for this procedure typically include:
- Individuals suffering from Dry AMD (geographic atrophy or drusen accumulation) who have noticed progressive visual changes but retain viable retinal structure.
- Patients with early to moderate Wet AMD whose condition is currently stable and actively managed by their primary home ophthalmologist.
- Patients seeking a complementary strategy aiming to provide trophic support to struggling tissues to potentially slow disease progression, rather than seeking an immediate cure.
- Individuals in good general health without active systemic infections, active oncological conditions, or unmanaged severe systemic illnesses.
Every prospective patient is thoroughly evaluated on a case-by-case basis by the medical team at Integra Medical Center to ensure the treatment is both safe and potentially beneficial.
Required Medical Records for Preliminary Assessment
Before making any travel arrangements, the medical team will need to review specific documents remotely to determine eligibility and outline a safe protocol. You will generally be asked to provide:
- Recent Ophthalmic Examination Reports: Comprehensive clinical notes from your primary ophthalmologist or retina specialist, ideally completed within the past 3 to 6 months.
- Optical Coherence Tomography (OCT) Scans: High-resolution cross-sectional images of your retina that demonstrate macular thickness and tissue integrity.
- Visual Field or Angiography Records: Recent fluorescein angiography reports or visual field test results to help establish baseline function.
- Comprehensive Medical History: A detailed summary of past surgeries, ongoing chronic conditions, and previous major health events.
- Current Medication List: Every prescription, over-the-counter medication, specific eye drops, and supplement you take daily.
Understanding the Stem Cell Procedure
The goal of stem cell therapy for macular degeneration is to utilize the body's natural regenerative and anti-inflammatory properties to support ocular health. When the delicate retinal pigment epithelium (RPE) cells and light-sensing photoreceptors experience chronic stress and deterioration in AMD, visual loss occurs. Stem cell therapy approaches this by introducing specialized stem cells into the body. Rather than instantly turning into new eye cells directly, these cells act largely through "paracrine signaling" releasing a steady stream of growth factors, anti-inflammatory proteins, and healing signals. This encourages surrounding cells to repair themselves, aiming to stabilize the ocular environment. The cells may be administered through a standard intravenous (IV) drip or localized delivery techniques, ensuring your comfort throughout.
Timeline of Treatment and Travel
Planning a medical trip requires a clear understanding of the schedule. Here is a typical timeline for the process:
Step 1: Remote Assessment & Pre-Travel Planning
You will submit your recent OCT scans, eye records, and medical history online. Our physicians review your documents to confirm eligibility, outline a proposed protocol, and provide a clear pricing breakdown before you schedule your visit.
Step 2: Arrival & Initial Consultation (Day 1)
You arrive in the border area and proceed to Integra Medical Center in Nuevo Progreso. You will meet face-to-face with your attending physician for a detailed consultation, physical exam, and a gentle discussion of the precise details of your upcoming procedure.
Step 3: Clinical Treatment Day (Day 2)
You return to the clinic for your stem cell administration. The treatment is carried out under strict sterile protocols. Afterwards, you will relax in our recovery room under medical monitoring before being cleared to rest at your hotel.
Step 4: Post-Procedure Check & Medical Clearance (Day 3 or 4)
A follow-up appointment is conducted at the clinic to check your vital signs, evaluate your immediate recovery status, and review post-treatment instructions. Once medically cleared, you may begin your journey home.
Step 5: Home Recovery & Long-Term Follow-Up (Months 1 to 6)
Back home, you resume normal routines while avoiding heavy physical strain initially. We stay in regular contact to track your progress, while you continue routine check-ups with your local ophthalmologist.
Expected Length of Stay
For patients traveling to Integra Medical Center for this therapy, we recommend planning an overall trip length of approximately 3 to 4 days. This timeframe accommodates your initial face-to-face evaluation, the treatment procedure itself, and a mandatory post-procedure rest day. Attempting to rush in and out on the same day can induce unnecessary physical stress, which is counterproductive to healing. Final travel clearance always depends entirely on the treating physician’s evaluation of your recovery.
Recovery and Post-Treatment Aftercare
Because the procedure is minimally invasive, physical recovery is generally smooth, but allowing your body adequate time to rest is critical. In the immediate 24 to 72 hours following the infusion, you may experience mild fatigue or slight soreness at the IV or injection sites. You must stick to a restful routine and avoid exposing your eyes to harsh, bright environments without UV-blocking sunglasses.
During the first month, continue to avoid excessive physical strain. If you received localized ocular support, you must meticulously follow instructions to avoid rubbing your eyes to prevent irritation. Long-term aftercare involves continuing standard check-ups with your primary home ophthalmologist to monitor retinal stability over the ensuing months.
Understanding the Risks and Complications
Any medical procedure carries inherent risks, and it is vital for patients to be fully informed. While stem cell infusions are generally well-tolerated, potential risks include:
- Localized infection, bruising, minor bleeding, or mild inflammation at the IV or injection site.
- Transient low-grade fever, fatigue, or mild headaches as an immune response to cellular infusion.
- Rare but serious ophthalmic risks if localized ocular procedures are utilized, such as elevated intraocular pressure or retinal tears.
- The possibility that the treatment yields no measurable improvement in central vision or fails to halt disease progression.
This list is not exhaustive. The treating physician will conduct a thorough informed consent discussion outlining all individual risks based on your specific health profile prior to beginning any treatment.
What Results Can Patients Reasonably Expect?
The primary therapeutic objective of stem cell therapy in AMD is retinal tissue preservation and stabilization, rather than serving as a miraculous cure for blindness. While outcomes vary significantly from person to person depending on genetics and baseline disease severity, patients may experience:
- Stabilization of their current visual field and a slowing of progressive tissue degeneration.
- Reduced localized inflammation within the ocular environment.
- Subtle improvements in contrast sensitivity or light perception.
Improvements typically manifest gradually over a period of 3 to 6 months following administration as cellular signals interact with host tissues. We encourage all patients to view cellular therapy as a supportive, complementary tool within a broader commitment to eye health management.
Medical Center Profile: Integra Medical Center
Integra Medical Center is a well-established healthcare facility located in Nuevo Progreso, Tamaulipas, Mexico a safe, highly frequented border town recognized for welcoming thousands of international patients seeking high-quality, accessible regenerative health services. Under the clinical guidance of experienced physicians who have focused extensive attention on regenerative applications, the clinic operates with a strong emphasis on patient safety, strict sanitation protocols, and ethical treatment practices.
Understanding the unique needs of international visitors, Integra Medical Center provides a warm, welcoming atmosphere supported by fully bilingual medical and administrative staff. From your initial remote consultation through your on-site appointments and follow-up care, the team ensures clear communication, helping eliminate language barriers and allowing you to feel fully supported throughout your healthcare journey.
Frequently Asked Questions About Stem Cell Therapy
1. Is stem cell therapy a guaranteed cure for macular degeneration?
No, stem cell therapy is not a cure for macular degeneration. Currently, modern science has not discovered a permanent cure for AMD. Stem cell administration is utilized as an advanced supportive therapeutic intervention aiming to provide cellular nourishment and potentially slow down disease progression, but results vary per individual.
2. Does the procedure cause significant pain or discomfort?
The treatment is designed to be minimally invasive and comfortable. Intravenous administration involves a standard IV needle insertion, similar to routine blood work. If localized delivery is recommended, local numbing agents are utilized to ensure you feel little to no physical pain during the process.
3. How long does it take to see potential visual improvements?
Biological recovery and paracrine signaling happen gradually. Unlike immediate corrective surgery, potential benefits from cellular therapy—such as improved contrast or visual stabilization typically unfold slowly over 3 to 6 months following the procedure.
4. Where do the stem cells used in this package come from?
The clinic utilizes adult stem cells, such as autologous cells (derived from your own tissue) or ethically screened allogeneic adult stem cells (such as umbilical cord tissue-derived mesenchymal cells). The specific source is chosen based on physician recommendation and patient safety.
5. How does stem cell therapy differ from standard anti-VEGF eye injections?
Standard anti-VEGF injections for wet AMD specifically target chemical signals to suppress abnormal, leaking blood vessels. Stem cell therapy focuses on a broader regenerative approach, supplying growth factors and anti-inflammatory properties to support surviving retinal cells in both dry and stable wet AMD.
6. Is it safe to travel back home shortly after the treatment?
Yes, provided you receive formal clearance from the treating physician during your post-procedure follow-up. The medical team will check your vital signs and general stability before confirming you are safe to travel long distances.
7. Should I continue seeing my primary eye doctor at home?
Yes, absolutely. Stem cell therapy is intended to complement, not replace, your regular ophthalmic care. You should maintain all scheduled check-ups, diagnostic OCT scans, and routine treatments prescribed by your home eye care specialist.
8. Are there upper age restrictions for undergoing this package?
Age alone is generally not a strict disqualifying factor. Candidacy depends primarily on your overall systemic health, immune function, and the structural condition of your eyes, rather than your exact chronological age.
9. What if I have co-existing eye conditions like cataracts or glaucoma?
Co-existing conditions are evaluated during pre-travel record review. While minor cataracts do not automatically prevent treatment, conditions like uncontrolled glaucoma or severe active inflammation must be managed before cellular therapy can be safely considered.
10. Is this specific treatment procedure FDA-approved in the United States?
No, stem cell applications for macular degeneration are considered investigational and are not approved by the US FDA as standard clinical treatments. The procedure is provided in Mexico under the regulatory oversight and health guidelines established by Mexican authority COFEPRIS.
Take the Next Gentle Step Toward Supporting Your Vision
Navigating choices for progressive visual health shouldn't be an overwhelming journey. If you are ready to find out if you are a candidate for cellular therapy and want a personalized breakdown of what your treatment might look like, our empathetic team is ready to help review your case without obligation.
Request Free Quote and Medical AssessmentMedical Disclaimer: The information provided on this page is for general educational and informational purposes only and does not constitute medical advice, formal diagnosis, or direct treatment recommendations. Always seek the advice of your physician, ophthalmologist, or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment plan.

Share this listing